Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in IBRX — ImmunityBio, Inc.

CIK 923093 STAMFORD, CT

Position in IBRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$4,395,071 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
7 quarters on record

Common Shares in IBRX Over Time

Shares Held

Position Value (USD)

Derivatives in IBRX

reported options exposure · as of Jun 30, 2026
CallValue
$1,991,762
CallShares
227,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in IBRX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,991,762 227,500
2026-03-31 $1,349,920 176,000
2026-03-31 $4,395,071 573,021
2025-06-30 $43,314 16,407
2025-03-31 $73,001 24,253
2024-06-30 $638,610 101,046
2023-03-31 $357,513 196,436
2022-06-30 $353,920 95,140